These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8355865

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Effects of the synthetic proteinase inhibitor, FOY, on hypercoagulability after surgery for esophageal carcinoma].
    Usuba A, Motoki R, Koizumi Y, Oishi A, Endo Y, Konno O, Inoue H.
    Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):931-41. PubMed ID: 2122227
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [The effect of protease inhibitors in shock].
    Inoue H, Usuba A, Endo Y, Terashima S, Watanabe M, Miura J, Motoki R.
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1374-7. PubMed ID: 2511417
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro.
    Uchiba M, Okajima K, Kaun C, Binder BR, Wojta J.
    Crit Care Med; 2003 Apr; 31(4):1147-53. PubMed ID: 12682486
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of a protease inhibitor in the prevention of ischemia and reperfusion injury in hepatectomy under intermittent Pringle maneuver.
    Kim YI, Chung HJ, Song KE, Hwang YJ, Lee JW, Lee YJ, Chun BY.
    Am J Surg; 2006 Jan; 191(1):72-6. PubMed ID: 16399110
    [Abstract] [Full Text] [Related]

  • 30. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
    Taenaka N, Shimada Y, Hirata T, Nishijima MK, Takezawa J, Yoshiya I, Kambayashi J.
    Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group.
    Büchler M, Malfertheiner P, Uhl W, Schölmerich J, Stöckmann F, Adler G, Gaus W, Rolle K, Beger HG.
    Gastroenterology; 1993 Apr; 104(4):1165-70. PubMed ID: 8462805
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Successful treatment with continuous enteral protease inhibitor in a patient with severe septic shock.
    Lee YT, Wei J, Chuang YC, Chang CY, Chen IC, Weng CF, Schmid-Schönbein GW.
    Transplant Proc; 2012 Apr; 44(3):817-9. PubMed ID: 22483504
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. C5a inhibitory peptide combined with gabexate mesilate is a clinically available candidate for preventing the instant blood-mediated inflammatory reaction.
    Tokodai K, Goto M, Imura T, Ogawa N, Fujimori K, Kurokawa Y, Okada H, Satomi S.
    Transplant Proc; 2009 Apr; 41(1):67-8. PubMed ID: 19249478
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.